Get access to our best features
Get access to our best features
Published 4 years ago

Effectiveness confirmed by Fujifilm and Avigan Apply for manufacturing and marketing approval by the end of October

Summary
[Tokyo, 23rd, Reuters] --Fujifilm <4901.T> achieved its primary endpoint in the domestic phase III clinical trial of the new coronavirus drug candidate "Abigan" on the 23rd by its subsidiary Fujifilm Toyama Chemical. Announced.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 55% of the sources are Center
55% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics